(a) By HPTCL |
Drugs |
Conc.
(ng spot-1) |
Repeatability
(n= 6) |
Intermediate precision
(n= 6) |
Found conc. ± SD |
RSD (%) |
Found conc. ± SD |
RSD (%) |
Levocetirizine |
500 |
504.07 ± 2.12 |
0.42 |
499.95 ± 0.99 |
0.20 |
1500 |
1497.51± 27.10 |
1.81 |
1505.03± 27.84 |
1.85 |
2500 |
2509.37± 37.39 |
1.49 |
2501.53± 33.27 |
1.33 |
Montelukast sodium |
1000 |
998.50 ± 9.19 |
0.92 |
1009.04 ± 1.92 |
0.19 |
3000 |
3035.91 ± 6.07 |
0.20 |
2989.31± 12.26 |
0.41 |
5000 |
4955.98± 60.96 |
1.23 |
4911.08± 44.20 |
0.90 |
|
(b) By HPCL |
Drugs |
Conc.
(µg mL-1) |
|
|
Repeatability
(n= 6) |
Intermediate precision
(n= 6) |
Found conc. ± SD |
RSD (%) |
Found conc. ± SD |
RSD (%) |
Levocetirizine |
1 |
0.98 ± 0.002 |
0.20 |
1.008 ± 0.000 |
0.06 |
4 |
4.05 ± 0.014 |
0.34 |
4.142 ± 0.012 |
0.28 |
10 |
9.97 ± 0.007 |
0.07 |
10.280 ± 0.005 |
0.04 |
Montelukast sodium |
2 |
1.98 ± 0.002 |
0.10 |
1.960 ± 0.003 |
0.15 |
8 |
8.82 ± 0.050 |
0.06 |
8.180 ± 0.006 |
0.07 |
20 |
20.860 ± 0.020 |
0.10 |
19.910 ± 0.008 |
0.04 |
|
Table 2: Precision studies |